Ambeed.cn

首页 / / / / Eleutheroside E/刺五加苷E

Eleutheroside E/刺五加苷E {[allProObj[0].p_purity_real_show]}

货号:A593928 同义名: 刺五加甙E / Syringin E

Eleutheroside E是五味子(Eleutherococcus senticosus)的主要成分,在缺血性心脏病中具有抗炎和保护作用。

Eleutheroside E/刺五加苷E 化学结构 CAS号:39432-56-9
Eleutheroside E/刺五加苷E 化学结构
CAS号:39432-56-9
Eleutheroside E/刺五加苷E 3D分子结构
CAS号:39432-56-9
Eleutheroside E/刺五加苷E 化学结构 CAS号:39432-56-9
Eleutheroside E/刺五加苷E 3D分子结构 CAS号:39432-56-9
规格 价格 会员价 库存 数量
{[ item.pr_size ]} {[ size_append(item.pr_size_append, item.pr_am, item.pr_size) ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} 现货 1周 咨询 - +
购物车0 收藏 询单

Eleutheroside E/刺五加苷E 纯度/质量文件 产品仅供科研

货号:A593928 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

Nature, 2025, 645, 793-800. Ambeed. [ A201204 , A444152 , A344107 , A952055 ]
Cell, 2025, 188, (21): 5847-5861.e11. Ambeed. [ A122167 ]
Science, 2025, 387(6729): eadp5637. Ambeed. [ A875019 ]
Sig. Transduct. Target. Ther., 2025, 10, 257. Ambeed. [ A104916 ]
Nat. Nanotechnol., 2025, 20, 1502-1513. Ambeed. [ A243018 , A1216705 , A522597 , A125401 , A1355641 ]
更多 >

Eleutheroside E/刺五加苷E 生物活性

描述 Eleutheroside E (EE), a principal component of Eleutherococcus senticosus (ES), has anti-inflammatory and protective effects in ischemia heart. EE increased the insulin-provoked glucose uptake in C2C12 myotubes. Moreover, EE improved TNF- α -induced suppression of glucose uptake in 3T3-L1 adipocytes. EE mediates the hyperglycemic effects of ES by regulating insulin signaling and glucose utilization[3]. The IC50 values for EB and EE were calculated to be 193.20 μM and 188.36 μM for CYP2E1, 595.66 μM and 261.82 μM for CYP2C9, respectively[4]. EE administration attenuated the cardiomyocyte apoptosis induced by hypoxia-reoxygenation (H/R) injury. Further, pre-treatment with EE dramatically inhibited mitochondrial oxidative stress, IκBα phosphorylation and nuclear factor kappa B (NF-κB) subunit p65 translocation into nuclei. EE might suppress the MAPK signaling pathway to inhibit the H/R-induced NF-κB activation. EE may be a potential drug for myocardial I/R injury by reducing oxidative stress, NF-κB activation, and metabolic reprogramming[5].

Eleutheroside E/刺五加苷E 细胞实验

Cell Line
Concentration Treated Time Description References
PC12 cells 100, 10, 1, 0.1 mg/mL 24 hours To evaluate the effect of Eleutheroside E on PC12 cell viability, results showed no significant effect on PC12 cell viability Neural Regen Res. 2012 Aug 25;7(24):1845-50
PC-12 cells 100 μmol/L, 300 μmol/L, 500 μmol/L 24 hours To investigate the protective effect of Eleutheroside E on the MPTP-induced Parkinson’s disease cell model. Results showed that compared with the MPTP group, the survival rates of cells at low, medium, and high concentrations of eleutheroside E all increased. The mitochondrial membrane potential at medium and high concentrations of eleutheroside E increased. The ROS levels at medium and high concentrations of eleutheroside E decreased. Moreover, the apoptosis rate decreased and the expression levels of the intracellular proteins CytC, Nrf2, and NQO1 were upregulated. Molecules. 2023 Apr 29;28(9):3820

Eleutheroside E/刺五加苷E 动物实验

Species
Animal Model
Administration Dosage Frequency Description References
Kunming mice 60Co-γ radiation model Oral 50 mg/kg/d Once daily for 4 weeks Eleutheroside E supplementation improved cognition and spatial memory impairments in irradiated mice, protected hippocampal neurons, remodeled gut microbiota, especially changes in Lactobacillus and Helicobacter, and altered microbial metabolites including neurotransmitters (GABA, NE, ACH, 5-HT) and their precursors. Furthermore, fecal transplantation from EE donors verified that EE alleviated cognition and spatial memory impairments and activated the PKA/CREB/BDNF signaling pathway via gut microbiota. Commun Biol. 2022 Jul 8;5(1):680
Wistar rats Ovariectomized osteoporosis model Oral 0.1g/kg Once daily for 4 weeks To evaluate the therapeutic effect of Eleutheroside E on ovariectomized osteoporosis model rats, it was found to significantly regulate 21 biomarkers, mainly involving steroid hormone biosynthesis, arachidonic acid metabolism, and primary bile acid biosynthesis. Front Pharmacol. 2020 Aug 26;11:1316
Wistar rats Ovariectomized osteoporosis model Oral 0.1g/kg Once daily for 4 weeks Evaluate the intervention effect of Eleutheroside E on ovariectomized osteoporosis model rats, regulating 21 biomarkers, mainly involving steroid hormone biosynthesis, arachidonic acid metabolism, and primary bile acid biosynthesis Front Pharmacol. 2020 Aug 26;11:1316
Rats Cerebral ischemia-reperfusion injury model Gavage 10 mg/kg Once daily for 21 days To evaluate the protective effect of Eleutheroside E on cerebral ischemia-reperfusion injury, results showed that Eleutheroside E significantly reduced cerebral infarct volume and improved neurological deficits. Bioengineered. 2022 May;13(5):11718-11731
Kunming mice Radiation-induced brain injury model Intragastric administration 204.6 μg/kg/d Once daily for 14 days Eleutheroside E significantly improved learning and memory ability impairment in irradiated mice, protected neurons, increased antioxidant activity, and regulated neurotransmitter levels. Molecules. 2022 Feb 7;27(3):1106

Eleutheroside E/刺五加苷E 参考文献

[1]Yang X, Wang Y, et al. High glucose induces rat mesangial cells proliferation and MCP-1 expression via ROS-mediated activation of NF-κB pathway, which is inhibited by eleutheroside E. J Recept Signal Transduct Res. 2016;36(2):152-7.

[2]Ahn J, Um MY, et al. Eleutheroside E, An Active Component of Eleutherococcus senticosus, Ameliorates Insulin Resistance in Type 2 Diabetic db/db Mice. Evid Based Complement Alternat Med. 2013;2013:934183.

[3]Ahn J, Um MY, Lee H, Jung CH, Heo SH, Ha TY. Eleutheroside E, An Active Component of Eleutherococcus senticosus, Ameliorates Insulin Resistance in Type 2 Diabetic db/db Mice. Evid Based Complement Alternat Med. 2013;2013:934183

[4]Guo S, Liu Y, Lin Z, Tai S, Yin S, Liu G. Effects of eleutheroside B and eleutheroside E on activity of cytochrome P450 in rat liver microsomes. BMC Complement Altern Med. 2014 Jan 2;14:1

[5]Wang S, Yang X. Eleutheroside E decreases oxidative stress and NF-κB activation and reprograms the metabolic response against hypoxia-reoxygenation injury in H9c2 cells. Int Immunopharmacol. 2020 Jul;84:106513

Eleutheroside E/刺五加苷E 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.35mL

0.27mL

0.13mL

6.73mL

1.35mL

0.67mL

13.46mL

2.69mL

1.35mL

Eleutheroside E/刺五加苷E 技术信息

CAS号39432-56-9
分子式C34H46O18
分子量 742.72
SMILES Code COC(C=C1[C@H]2[C@@](CO[C@@H]3C4=CC(OC)=C(O[C@@H]([C@@H]([C@@H](O)[C@@H]5O)O)O[C@@H]5CO)C(OC)=C4)([H])[C@]3([H])CO2)=C(C(OC)=C1)O[C@@H]([C@@H]([C@@H](O)[C@@H]6O)O)O[C@@H]6CO
MDL No. MFCD20036283
别名 刺五加甙E ;Syringin E
运输蓝冰
存储条件

In solvent -20°C: 3-6个月 -80°C: 12个月

Pure form Sealed in dry, 2-8°C

溶解方案

DMSO: 105 mg/mL(141.37 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

H2O: 1 mg/mL(1.35 mM),配合低频超声助溶

请根据您的动物给药指南选择适当的溶解方案。
以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂:
——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
方案 一
方案 二
方案 三
AmBeed 相关网站 AmBeed.cn AmBeed.com
AmBeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    AmBeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。